Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

Share Price is delayed by 15 minutes
Get Live Data
64.50    -0.30 (-0.46%)
Bid:
64.50
Ask:
65.00
Spread: 0.50 (0.775%)
Market Cap: £100.40m
MACF Live PriceLast checked at - London Stock Exchange

Intraday Macfarlane Grp. Share Chart

AGM Statement

12 May 2020 12:00

RNS Number : 6434M
Macfarlane Group PLC
12 May 2020
Β 

Β 

12 May 2020

Β 

At the Annual General Meeting ("AGM") held in Glasgow today, Stuart Paterson, Chairman of Macfarlane Group PLC ("Macfarlane" or the "Company") made the following statement.

Trading

As previously reported in our COVID-19 update on 30 March 2020, the first quarter of 2020 delivered a strong trading performance with Group sales growth of 2% and profitability well ahead of the same period in 2019. The acquisitions made in 2019 both performed to expectations in this period.

As a result of Government actions to address the COVID-19 crisis, we expect demand levels in the second quarter to reduce to between 75% and 80% of those seen in the second quarter of 2019. We are managing our cost base in line with the reduced levels of activity and we would expect the second quarter to be a profitable period of trading albeit well below that achieved in the first quarter.

Customers

Following the introduction of "lockdown" by the Government, our customers in the hygiene, household essentials, medical and food sectors continue to demonstrate strong demand. These customers play a vital role in helping to meet the challenges of COVID-19 and we continue to support them. All our sites remain operational, we are fully engaged with customers and offering an increasingly flexible service in response to their fast-changing needs. Some sectors we serve, such as automotive, aerospace and certain retail segments, have been materially impacted by the lockdown and their business has reduced significantly as a result.

People

The Board is committed to following the Government's guidance for COVID-19. Our intention during this challenging period is to ensure that we protect the health and wellbeing of our people. We have implemented home working programmes, workplace distancing and enhanced hygiene protocols. In line with the UK Government's aim to preserve employment we have furloughed approximately 30% of staff through the Coronavirus Job Retention Scheme.

The Board wishes to express its gratitude to all Macfarlane staff for their commitment, support and flexibility in these challenging times.

Liquidity

The Company has a strong balance sheet and liquidity headroom. Net bank debt, which at 31 December 2019 was Β£12.7 million, has now reduced below Β£6.0 million, albeit with the benefit of taxation deferrals, board salary reductions and bonus deferrals which in total amount to Β£4.0m. Following the actions taken, there remains significant headroom on the Group's principal bank facility of up to Β£30.0 million with Lloyds Banking Group, which is available until June 2022. The Company is in compliance with the covenants for the facility.

As a key measure to conserve cash, the Board took the decision not to propose the 2019 final dividend at today's AGM, which will reduce cash outflows by Β£2.8 million in the second quarter of 2020. The Company has been a regular dividend payer for a number of years and the Board remains committed to providing dividend income to shareholders. Once trading has recovered in line with more normal levels and we have more clarity about the longer-term outlook, the Board's intention is to recommence dividend payments either by augmenting regular dividends or by declaring a special dividend.

Β 

Summary

Given the current uncertainty and concerns around the pace of the potential recovery, it is not possible for the Company to provide meaningful guidance on trading for the financial year ending 31 December 2020. However, based on actions taken to date and current levels of trading, we expect the business to remain profitable in 2020 and to operate within the current borrowing facility. Further announcements will be made on the anticipated 2020 performance when the Board has more clarity.

Β 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Β 

Stuart Paterson Chairman

Β 

Β 

Peter Atkinson Chief Executive

Β 

Β 

John Love Finance Director

Β 

Β 

Β 

Β 

Β 

Spreng Thomson

Tel: 0141 548 5191

Β 

Callum Spreng

Mob: 07803 970103

Legal Entity Identifier (LEI): 213800LVRYDERSJAAZ73

Β 

Notes to Editors:

Β· Macfarlane Group PLC is listed on the London Stock Exchange (LSE: MACF) in the Industrials Sector

Β· The company is headquartered in Glasgow, Scotland and has more than 70 years' experience in the UK packaging industry. Macfarlane Group's businesses are:

o Macfarlane Packaging is the leading UK distributor of a comprehensive range of protective packaging products

o Labels designs and prints high quality self-adhesive and resealable labels, principally for FMCG companies

o Packaging Design and Manufacture designs and produces protective packaging for high value, fragile products

Β· Macfarlane Group employs over 925 people at 31 sites, principally in the UK, but also in Ireland and Sweden.

Β· The company has 15,000+ customers in the UK, Europe and the USA providing 600,000+ lines to a wide range of industry sectors including: consumer goods; food manufacturing; logistics; internet retail; mail order; electronics; defence and aerospace.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
AGMSFAFSEESSEFI
Date   Source Headline
17th May 20192:20 pmRNSDirector/PDMR Shareholding
14th May 20193:21 pmRNSResult of AGM
14th May 201912:00 pmRNSAGM Statement
7th May 20197:00 amRNSAcquisition of Ecopac (UK) Limited
1st May 201911:35 amRNSHolding(s) in Company
4th Apr 201912:07 pmRNSAnnual Report and Notice of AGM
8th Mar 20194:26 pmRNSDirector Declaration
25th Feb 20191:15 pmRNSChange of Registered Office
21st Feb 20197:00 amRNSFinal Results
7th Jan 20192:45 pmRNSNotice of Results
4th Jan 20192:11 pmRNSHolding(s) in Company
19th Dec 20181:00 pmRNSDirector/PDMR Shareholding
14th Dec 20185:13 pmRNSDirector/PDMR Shareholding
12th Dec 201812:40 pmRNSHolding(s) in Company
10th Dec 20185:29 pmRNSHolding(s) in Company
27th Nov 201811:37 amRNSHolding(s) in Company
20th Nov 20187:00 amRNSInterim Management Statement
12th Sep 20189:22 amRNSHalf-year Report
28th Aug 20187:00 amRNSBoard Changes
23rd Aug 20187:00 amRNSHalf-year Report
20th Aug 20188:34 amRNSHolding(s) in Company
6th Jul 20189:54 amRNSNotice of Interim Results
15th May 20183:51 pmRNSResult of AGM
15th May 201812:00 pmRNSAGM Statement
4th Apr 20182:00 pmRNSAnnual Report and Notice of AGM
19th Mar 20181:14 pmRNSHolding(s) in Company
22nd Feb 20187:00 amRNSFinal Results
22nd Jan 201810:23 amRNSNotice of Results
8th Jan 20188:30 amRNSAppointment of Non-Executive Director
16th Nov 20177:00 amRNSInterim Management Statement
8th Nov 20175:54 pmRNSHolding(s) in Company
19th Oct 20172:53 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSDirectorate Change
26th Sep 201710:05 amRNSHolding(s) in Company
25th Sep 20178:22 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSCompletion of Acquisition and Total Voting Rights
21st Sep 20179:33 amRNSHolding(s) in Company
21st Sep 20178:16 amRNSHolding(s) in Company
18th Sep 201712:42 pmRNSResult of Oversubscribed Placing
18th Sep 20177:00 amRNSConditional acquisition and £8 million placing
12th Sep 201711:10 amRNSHalf-year Report
24th Aug 20177:00 amRNSHalf-year Report
14th Jul 20179:03 amRNSNotice of Results
6th Jul 20178:52 amRNSHolding(s) in Company
4th Jul 20179:06 amRNSHolding(s) in Company
3rd Jul 201710:19 amRNSDirector Declaration
9th May 20174:50 pmRNSResult of AGM
9th May 201712:00 pmRNSAGM Statement
3rd Apr 20179:46 amRNSAnnual Financial Report
10th Mar 20171:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.